MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

B-CoVita Compound tablets (Essential-Healthcare Ltd)

Explore other Nicotinamide + Riboflavine + Thiamine formulations Explore other Vitamin B compound tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

B-Max 1,000microgram capsules (Nutraconcepts Ltd)

Explore other Mecobalamin formulations Explore other Mecobalamin 1mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

B-Max 5,000microgram capsules (Nutraconcepts Ltd)

Explore other Mecobalamin formulations Explore other Mecobalamin 5mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Baclofen 10mg tablets (A A H Pharmaceuticals Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (AAH Hillcross)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Accord-UK Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Almus Pharmaceuticals Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Genesis Pharmaceuticals Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Manx Healthcare Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Medihealth (Northern) Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Noumed Life Sciences Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (RX Farma)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Use with caution

Baclofen 10mg tablets (Sigma Pharmaceuticals Plc)

Explore other Baclofen formulations Explore other Baclofen 10mg tablets suppliers

Stability Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.

Provenance

This recommendation is based on the products Lioresal 10mg (Novartis Pharmaceuticals UK Ltd) and Baclofen 5mg/20mg (ADVANZ Pharma).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.